MedPath

BRIGHTOUTCOME INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)

SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support

Not Applicable
Completed
Conditions
Alzheimer Disease
First Posted Date
2022-10-03
Last Posted Date
2023-10-24
Lead Sponsor
BrightOutcome
Target Recruit Count
15
Registration Number
NCT05562583
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice

Phase 1
Completed
Conditions
Breast Cancer
First Posted Date
2010-04-22
Last Posted Date
2012-02-06
Lead Sponsor
BrightOutcome
Target Recruit Count
138
Registration Number
NCT01108315
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

🇺🇸

Seattle Cancer Care Alliance, Seattle, Washington, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.